Analytical Data
-
基因名
LYPLA3
- Application
-
别名
LYPLA3；LYPLA3；Lysosomal phospholipase A and acyltransferase
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8NCC3
-
表达区间
34-412aa
-
氨基酸序列
AGRHPPV VLVPGDLGNQ LEAKLDKPTV VHYLCSKKTE SYFTIWLNLE LLLPVIIDCW IDNIRLVYNK TSRATQFPDG VDVRVPGFGK TFSLEFLDPS KSSVGSYFHT MVESLVGWGY TRGEDVRGAP YDWRRAPNEN GPYFLALREM IEEMYQLYGG PVVLVAHSMG NMYTLYFLQR QPQAWKDKYI RAFVSLGAPW GGVAKTLRVL ASGDNNRIPV IGPLKIREQQ RSAVSTSWLL PYNYTWSPEK VFVQTPTINY TLRDYRKFFQ DIGFEDGWLM RQDTEGLVEA TMPPGVQLHC LYGTGVPTPD SFYYESFPDR DPKICFGDGD GTVNLKSALQ CQAWQSRQEH QVLLQELPGS EHIEMLANAT TLAYLKRVLL GP
-
分子量
46.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LYPLA3 (lysophospholipase I) is an important enzyme involved in lipid metabolism, particularly in the hydrolysis of lysophospholipids. Its role in cellular signaling and membrane dynamics has drawn significant attention in recent years, especially due to its association with various diseases, including cancer and metabolic disorders. Research has shown that LYPLA3 may influence cell growth, differentiation, and apoptosis through its enzymatic activity and interactions with other cellular pathways. The recombinant protein has been studied to elucidate its structural characteristics and functional roles in lipid metabolism. Advances in recombinant DNA technology have made it possible to produce LYPLA3 at scale for both in vitro and in vivo studies, facilitating the investigation of its pharmacological potential. Understanding LYPLA3's mechanisms of action not only enhances our knowledge of lipid biology but also opens up new avenues for therapeutic interventions targeting related pathologies. Thus, LYPLA3 recombinant protein serves as a valuable tool for researchers aiming to dissect the intricacies of lipid signaling and its implications in health and disease.
